Prognostic significance of forced vital capacity decline prior to and following antifibrotic therapy in idiopathic pulmonary fibrosis

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal interstitial lung disease (ILD). Currently, two antifibrotic drugs are available for reducing forced vital capacity (FVC) decline in IPF. However, many pulmonologists wait before initiating treatment, especially when IPF pati...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ther Adv Respir Dis
Main Authors: Aono, Yuya, Nakamura, Yutaro, Kono, Masato, Nakamura, Hidenori, Yokomura, Koshi, Imokawa, Shiro, Toyoshima, Mikio, Yasui, Hideki, Hozumi, Hironao, Karayama, Masato, Suzuki, Yuzo, Furuhashi, Kazuki, Enomoto, Noriyuki, Fujisawa, Tomoyuki, Inui, Naoki, Suda, Takafumi
Formato: Artigo
Idioma:Inglês
Publicado: SAGE Publications 2020
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7495940/
https://ncbi.nlm.nih.gov/pubmed/32928050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753466620953783
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares